Abou Jamra R, Becker T, Georgi A, Feulner T, Schumacher J, Stromaier J,
Schirmbeck F, Schulze TG, Propping P,
Rietschel M, Nöthen MM, Cichon S.
Genetic variation of the FAT gene at 4q35 is associated with bipolar affective disorder.
Mol Psychiatry. 2008 13(3):277-84.
Chandran D, Robbins DA, Chang CK, Shetty H, Sanyal J, Downs J, Fok M, Ball M, Jackson R, Stewart R, Cohen H, Vermeulen JM,
Schirmbeck F, de Haan L, Hayes R.
Use of Natural Language Processing to identify Obsessive Compulsive Symptoms in patients with schizophrenia, schizoaffective disorder or bipolar disorder.
Sci Rep. 2019 9(1):14146.
Eifler S, Rausch F,
Schirmbeck F, Veckenstedt R, Englisch S, Meyer-Lindenberg A, Kirsch P,
Zink M.
Neurocognitive capabilities modulate the integration of evidence in schizophrenia.
Psychiatry Res. 2014 219(1):72-8. Epub 2014 May 14.
Eifler S, Rausch F,
Schirmbeck F, Veckenstedt R, Mier D, Esslinger C, Englisch S, Meyer-Lindenberg A, Kirsch P,
Zink M.
Metamemory in schizophrenia: Retrospective confidence ratings interact with neurocognitive deficits.
Psychiatry Res. 2015 225(3):596-603. Epub 2014 Dec 2.
Eisenacher S, Rausch F, Ainser F, Mier D, Veckenstedt R,
Schirmbeck F, Lewien A, Englisch S, Andreou C, Moritz S, Meyer-Lindenberg A, Kirsch P,
Zink M.
Investigation of metamemory functioning in the at-risk mental state for psychosis.
Psychol Med. 2015 45(15):3329-40. epub 2015 Jul 23.
Englisch S, Esslinger C, Inta D, Weinbrenner A, Peus V, Gutschalk A,
Schirmbeck F,
Zink M.
Clozapine-induced obsessive-compulsive syndromes improve in combination with aripiprazole.
Clin Neuropharmacol. 2009 32(4):227-9.
Esslinger C, Braun U,
Schirmbeck F, Santos A, Meyer-Lindenberg A, Zink M,
Kirsch P.
Activation of Midbrain and Ventral Striatal Regions Implicates Salience Processing during a Modified Beads Task.
PLoS ONE. 2013 8(3):e58536.
Esslinger C, Englisch S, Inta D, Rausch F,
Schirmbeck F, Mier D, Kirsch P, Meyer-Lindenberg A,
Zink M.
Ventral striatal activation during attribution of stimulus saliency and reward anticipation is correlated in unmedicated first episode schizophrenia patients.
Schizophr Res. 2012 140(1-3):114-21. Epub 2012 Jul 9.
Faay MDM, van Os J, Genetic Risk and Outcome of Psychosis (GROUP) Investigators , ..... .....,
Schirmbeck F.
Aggressive Behavior, Hostility, and Associated Care Needs in Patients With Psychotic Disorders: A 6-Year Follow-Up Study.
Front Psychiatry. 2019 10:934.
Galinowski A, Miranda R, Lemaitre H, Paillère Martinot ML, Artiges E, Vulser H, Goodman R, Penttilä J, Struve M, Barbot A, Fadai T, Poustka L, Conrod P, Banaschewski T, Barker GJ, Bokde A, Bromberg U, Büchel C, Flor H, Gallinat J, Garavan H, Heinz A, Ittermann B, Kappel V, Lawrence C, Loth E, Mann K, Nees F, Paus T, Pausova Z, Poline JB,
Rietschel M, Robbins TW, Smolka M, Schumann G, Martinot JL, Spanagel R, Leonardi-Essmann F, Sommer WH, Vollstädt-Klein S, Steiner S, Fauth-Buehler M, Schmäl C,
Schirmbeck F, IMAGEN Consortium .
Resilience and corpus callosum microstructure in adolescence.
Psychol Med. 2015 45(11):2285-94. Epub 2015 Mar 30.
Georgi A, Schumacher J, Leon CA, Wolf AV, Klein K, Böhenz KV,
Schirmbeck F, Strohmaier J, Propping P, Schulze TG,
Rietschel M, Nöthen MM, Cichon S, Jamra RA.
No association between genetic variants at the DGCR2 gene and schizophrenia in a German sample.
Psychiatr Genet. 2009 19(2):104.
Habtewold TD, Islam MA, Liemburg EJ, GROUP Investigators , ..... .....,
Schirmbeck F, Bruggeman R, Alizadeh BZ.
Polygenic risk score for schizophrenia was not associated with glycemic level (HbA1c) in patients with non-affective psychosis: Genetic Risk and Outcome of Psychosis (GROUP) cohort study.
J Psychosom Res. 2020 132:109968.
Habtewold TD, Liemburg EJ, Islam MA, de Zwarte SM, Boezen HM, GROUP Investigators , ..... ....., Schirmbeck F, Bruggeman R, Alizadeh BZ. Association of schizophrenia polygenic risk score with data-driven cognitive subtypes: A six-year longitudinal study in patients, siblings and controls. Schizophr Res. 2020 223:135-147.
Hagen JM, Sutterland AL,
Schirmbeck F, Cohn DM, Lok A, Tan HL, Zwinderman AH, de Haan L.
Skin autofluorescence of advanced glycation end products and course of affective disorders in the lifelines cohort study, a prospective investigation.
J Affect Disord. 2020 276:424-432.
Hagen JM, Sutterland AL, da Fonseca Pereira de Sousa PAL,
Schirmbeck F, Cohn DM, Lok A, Tan HL, Zwinderman AH, de Haan L.
Association between skin autofluorescence of advanced glycation end products and affective disorders in the lifelines cohort study.
J Affect Disord. 2020 275:230-237.
Hasson-Ohayon I, Scholte-Stalenhoef AN,
Schirmbeck F, de Haan L, Cahn W, Pijnenborg GHM, Boyette LL, For GROUP .
Insight, personality, and symptoms among individuals with psychosis: Cross-sectional and longitudinal relationships.
Schizophr Res. 2020 222:243-250.
Islam MA, Habtewold TD, van Es FD, Quee PJ, van den Heuvel ER, Alizadeh BZ, Bruggeman R, GROUP Investigators , ..... ....., Schirmbeck F. Long-term cognitive trajectories and heterogeneity in patients with schizophrenia and their unaffected siblings. Acta Psychiatr Scand. 2018 138(6):591-604.
Liemburg EJ, Enriquez-Geppert S, Wardenaar KJ, Bruggeman R, Aleman A, PROGR-S investigators , GROUP investigators , ..... .....,
Schirmbeck F,
Schirmbeck F.
Expressive deficits and amotivation as mediators of the associations between cognitive problems and functional outcomes: Results from two independent cohorts.
Schizophr Res. 2020 218:283-291.
Mansueto G, Schruers K, Cosci F, van Os J, GROUP Investigators , ..... .....,
Schirmbeck F.
Childhood adversities and psychotic symptoms: The potential mediating or moderating role of neurocognition and social cognition.
Schizophr Res. 2019 206:183-193.
Mansueto G, van Nierop M, Schruers K, GROUP Investigators , Alizadeh BZ, Bartels-Velthuis AA, van Beveren NJ, Bruggeman R, Cahn W, de Haan L, Delespaul P, Meijer CJ, Myin-Germeys I, Kahn RS,
Schirmbeck F, Simons CJP, Van Haren NE, van Os J, van Winkel R.
The role of cognitive functioning in the relationship between childhood trauma and a mixed phenotype of affective-anxious-psychotic symptoms in psychotic disorders.
Schizophr Res. 2018 192:262-268.
Mier D,
Schirmbeck F, Stoessel G, Esslinger C, Rausch F, Englisch S, Eisenacher S, de Haan L,
Meyer-Lindenberg A, Kirsch P, Zink M.
Reduced activity and connectivity of left amygdala in patients with schizophrenia treated with clozapine or olanzapine.
Eur Arch Psychiatry Clin Neurosci. 2019 269(8):931-940. Epub 2018 Dec 11.
Moritz S, Ramdani N, Klass H, Andreou C, Jungclaussen D, Eifler S, Englisch S,
Schirmbeck F, Zink M.
Overconfidence in incorrect perceptual judgments in patients with schizophrenia.
Schizophr Res Cogn. 2014 1(4):165-170.
Müller D,
Schirmbeck F, de Haan L.
[Recommendations regarding diagnosis and treatment of obsessive-compulsive symptoms in schizophrenia].
Tijdschr Psychiatr. 2016 58(7):529-34.
Nymberg C, Banaschewski T, Bokde AL, Büchel C, Conrod P, Flor H, Frouin V, Garavan H, Gowland P, Heinz A, Ittermann B, Mann K, Martinot JL, Nees F, Paus T, Pausova Z,
Rietschel M, Robbins TW, Smolka MN, Ströhle A, Schumann G, Klingberg T, Spanagel R, Leonardi-Essmann F, Sommer WH, Vollstädt-Klein S, Poustka L, Steiner S, Fauth-Bühler M, Schmäl C,
Schirmbeck F, IMAGEN consortium .
DRD2/ANKK1 Polymorphism Modulates the Effect of Ventral Striatal Activation on Working Memory Performance.
Neuropsychopharmacology. 2014 39(10):2357-65. Epub 2014 Apr 9.
Paillère Martinot ML, Lemaitre H, Artiges E, Miranda R, Goodman R, Penttilä J, Struve M, Fadai T, Kappel V, Poustka L, Conrod P,
Banaschewski T, Barbot A, Barker GJ, Büchel C, Flor H, Gallinat J, Garavan H, Heinz A, Ittermann B, Lawrence C, Loth E, Mann K, Paus T, Pausova Z, Rietschel M, Robbins TW, Smolka MN, Schumann G, Martinot JL, Leonardi-Essmann F, Spanagel R, Sommer WH, Vollstädt-Klein S, Nees F, Steiner S, Fauth-Bühler M, Schmäl C,
Schirmbeck F, IMAGEN consortium .
White-matter microstructure and gray-matter volumes in adolescents with subthreshold bipolar symptoms.
Mol Psychiatry. 2014 19(4):462-70.
Petrie KJ, Müller JT, Schirmbeck F, Donkin L, Broadbent E, Ellis CJ, Gamble G, Rief W. Effect of providing information about normal test results on patients' reassurance: randomised controlled trial. BMJ. 2007 334(7589):352.
Pos K, Franke N, Smit F, Wijnen BFM, Staring ABP, van der Gaag M, Meijer C, de Haan L, Velthorst E,
Schirmbeck F.
Cognitive behavioral therapy for social activation in recent-onset psychosis: Randomized controlled trial.
J Consult Clin Psychol. 2019 87(2):151-160.
Pos K, de Wit IE, van Dijk FA, Bartels-Velthuis AA, Bruggeman R, Meijer CJ, de Haan L, for Group , Genetic Risk and Outcome of Psychosis investigators , Alizadeh BZ, van Beveren NJ, Cahn W, Delespaul P, Myin-Germeys I, Kahn RS,
Schirmbeck F, Simons CJP, van Haren NE, van Os J, van Winkel R.
An experience sampling study on the ecological validity of the SWN-20: Indication that subjective well-being is associated with momentary affective states above and beyond psychosis susceptibility.
Psychiatry Res. 2017 258:234-238.
Rausch F, Eifler S, Esser A, Esslinger C,
Schirmbeck F, Meyer-Lindenberg A,
Zink M.
The Early Recognition Inventory ERIraos detects at risk mental states of psychosis with high sensitivity.
Compr Psychiatry. 2013 54(7):1068-76. Epub 2013 Jun 4.
Rausch F, Mier D, Eifler S, Esslinger C, Schilling C,
Schirmbeck F, Englisch S, Meyer-Lindenberg A, Kirsch P,
Zink M.
Reduced activation in ventral striatum and ventral tegmental area during probabilistic decision-making in schizophrenia.
Schizophr Res. 2014 156(2-3):143-9. Epub 2014 May 13.
Rausch F, Mier D, Eifler S, Fenske S,
Schirmbeck F, Englisch S, Schilling C, Meyer-Lindenberg A, Kirsch P,
Zink M.
Reduced activation in the ventral striatum during probabilistic decision-making in patients in an at-risk mental state.
J Psychiatry Neurosci. 2015 40(3):163-73. Epub 2015 Jan 27.
Renkema TC, de Haan L,
Schirmbeck F, GROUP Investigators .
Childhood trauma and coping in patients with psychotic disorders and obsessive-compulsive symptoms and in un-affected siblings.
Child Abuse Negl. 2020 99:104243.
Rietschel M, Beckmann L, Strohmaier J, Georgi A, Karpushova A,
Schirmbeck F, Boesshenz KV, Schmäl C, Bürger C, Jamra RA, Schumacher J, Höfels S, Kumsta R, Entringer S, Krug A, Markov V, Maier W, Propping P, Wüst S, Kircher T, Nöthen MM, Cichon S, Schulze TG.
G72 and its association with major depression and neuroticism in large population-based groups from Germany.
Am J Psychiatry. 2008 165(6):753-62.
Rietschel M, Georgi A, Schmael C,
Schirmbeck F, Strohmaier J, Boesshenz KV, Schwarz M, Nöthen MM, Schulze TG.
Premorbid adjustment: A phenotype highlighting a distinction rather than an overlap between schizophrenia and bipolar disorder.
Schizophr Res. 2009 110(1-3):33-9. Epub 2009 Apr 3.
Schirmbeck F, Boyette LL, van der Valk R, Meijer C, Dingemans P, Van R, de Haan L, GROUP , Kahn RS, van Os J, Wiersma D, Bruggeman R, Cahn W, Myin-Germeys I.
Relevance of Five-Factor Model personality traits for obsessive-compulsive symptoms in patients with psychotic disorders and their un-affected siblings.
Psychiatry Res. 2015 225(3):464-70.
Schirmbeck F, Esslinger C, Rausch F, Englisch S, Meyer-Lindenberg A,
Zink M.
Antiserotonergic antipsychotics are associated with obsessive-compulsive symptoms in schizophrenia.
Psychol Med. 2011 41(11):2361-73.
Schirmbeck F, Georgi A, Strohmaier J, Schmael C, Boesshenz KV, Mühleisen TW, Herms S, Hoffmann P, Jamra RA, Schumacher J, Maier W, Propping P, Nöthen MM, Cichon S,
Rietschel M, Schulze TG.
Brief report: no association between premorbid adjustment in adult-onset schizophrenia and genetic variation in Dysbindin.
J Autism Dev Disord. 2008 38(10):1977-81.
Schirmbeck F, Georgi A, Strohmaier J, Schmael C, Knorr C, Jamra RA, Schumacher J, Becker T, Klopp N, Illig T, Wulf M, Schwarz M, Maier W, Propping P, Cichon S, Nöthen MM, Schulze TG,
Rietschel M.
No association between the serine racemase gene (SRR) and bipolar disorder in a German case-control sample.
Psychiatr Genet. 2007 17(2):127.
Schirmbeck F, Konijn M, Hoetjes V, Vermeulen J,
Zink M, Dekker J, de Haan L, for GROUP .
Stressful experiences affect the course of co-occurring obsessive-compulsive and psychotic symptoms: A focus on within-subject processes.
Schizophr Res. 2020 216:69-76. Epub 2020 Jan 7.
Schirmbeck F, Konijn M, Hoetjes V,
Zink M, de Haan L, For Genetic Risk and Outcome of Psychosis (GROUP) .
Obsessive-compulsive symptoms in psychotic disorders: longitudinal associations of symptom clusters on between- and within-subject levels.
Eur Arch Psychiatry Clin Neurosci. 2019 269(2):245-255. Epub 2018 Mar 8.
Schirmbeck F, Mier D, Esslinger C, Rausch F, Englisch S, Eifler S, Meyer-Lindenberg A, Kirsch P,
Zink M.
Increased orbitofrontal cortex activation associated with "pro-obsessive" antipsychotic treatment in patients with schizophrenia.
J Psychiatry Neurosci. 2015 40(2):89-99. Epub 2014 Sep 30.
Schirmbeck F, Nieratschker V, Frank J, Englisch S, Rausch F, Meyer-Lindenberg A, Rietschel M,
Zink M.
Polymorphisms in the glutamate transporter gene SLC1A1 and obsessive-compulsive symptoms induced by second-generation antipsychotic agents.
Psychiatr Genet. 2012 22(5):245-52. Epub 2012 Apr 23.
Schirmbeck F, Rausch F, Englisch S, Eifler S, Esslinger C, Meyer-Lindenberg A,
Zink M.
Differential effects of antipsychotic agents on obsessive-compulsive symptoms in schizophrenia: a longitudinal study.
J Psychopharmacol. 2013 27(4):349-57. Epub 2012 Oct 24.
Schirmbeck F, Rausch F, Englisch S, Eifler S, Esslinger C, Meyer-Lindenberg A,
Zink M.
Stable Cognitive Deficits in Schizophrenia Patients With Comorbid Obsessive-Compulsive Symptoms: A 12-Month Longitudinal Study.
Schizophr Bull. 2013 39(6):1261-71. Epub 2012 Oct 27.
Schirmbeck F, Swets M, Meijer CJ, Zink M, de Haan L, GROUP Investigators .
Longitudinal association between cognitive performance and obsessive-compulsive symptoms in patients with psychosis and unaffected siblings.
Acta Psychiatr Scand. 2016 133(5):399-409. Epub 2016 Feb 10.
Schirmbeck F, Swets M, Meijer CJ, Zink M, de Haan L, GROUP investigators .
Obsessive-compulsive symptoms and overall psychopathology in psychotic disorders: longitudinal assessment of patients and siblings.
Eur Arch Psychiatry Clin Neurosci. 2018 268(3):279-289. Epub 2016 Dec 17.
Schirmbeck F,
Zink M.
Clozapine-induced obsessive-compulsive symptoms in schizophrenia: a critical review.
Curr Neuropharmacol. 2012 10(1):88-95.
Schirmbeck F,
Zink M.
Comorbid obsessive-compulsive symptoms in schizophrenia: contributions of pharmacological and genetic factors.
Front Pharmacol. 2013 4:99_1-14.
Schneider S,
Schirmbeck F, Bock C, Greinert R, Breitbart EW, Diehl K.
Casting shadows on the prevalence of tanning dependence: an assessment of mCAGE criteria.
Acta Derm Venereol. 2015 95(2):162-8.
Schreuder MJ,
Schirmbeck F, Meijer C, de Haan L, GROUP Investigators .
The associations between childhood trauma, neuroticism and comorbid obsessive-compulsive symptoms in patients with psychotic disorders.
Psychiatry Res. 2017 254:48-53.
Schönfelder S,
Schirmbeck F, Waltereit R, Englisch S,
Zink M.
Aripiprazole improves olanzapine-associated obsessive compulsive symptoms in schizophrenia.
Clin Neuropharmacol. 2011 34(6):256-7.
Stiekema APM, Islam MA, Liemburg EJ, Castelein S, van den Heuvel ER, van Weeghel J, Aleman A, Bruggeman R, van der Meer L, GROUP investigators , Alizadeh BZ, Bartels-Velthuis AA, van Beveren NJ, Cahn W, de Haan L, Delespaul P, Meijer CJ, Myin-Germeys I, Kahn RS,
Schirmbeck F, Simons CJP, Van Haren NE, van Os J, van Winkel R.
Corrigendum to "Long-term course of negative symptom subdomains and relationship with outcome in patients with a psychotic disorder" [Schizophr. Res. 193 (2018) 173-181].
Schizophr Res. 2019 204:462-463.
Strohmaier J, Georgi A,
Schirmbeck F, Schmael C, Jamra RA, Schumacher J, Becker T, Höfels S, Klopp N, Illig T, Propping P, Cichon S, Nöthen MM,
Rietschel M, Schulze TG.
No association between the serine racemase gene (SRR) and schizophrenia in a German case-control sample.
Psychiatr Genet. 2007 17(2):125.
Swets M,
Schirmbeck F, Dekker J, de Haan L, Genetic Risk and Outcome of Psychosis (GROUP) Investigators .
Longitudinal association between motor and obsessive compulsive symptoms in patients with psychosis and their unaffected siblings.
Eur Arch Psychiatry Clin Neurosci. 2019 269(2):257-268.
Swets M, van Dijk FA,
Schirmbeck F, Peen J, de Haan L, Alizadeh BZ, van Amelsvoort T, Bartels-Velthuis AA, van Beveren NJ, Bruggeman R, Cahn W, Delespaul P, Luykx JJ, Myin-Germeys I, Kahn RS, Simons CJP, van Haren NE, van Os J, van Winkel R.
Patterns of obsessive-compulsive symptoms and social functioning in schizophrenia; a replication study.
Psychiatry Res. 2019 271:421-427.
Van Eck RM, Burger TJ, Schenkelaars M, Vellinga A, de Koning MB,
Schirmbeck F, Kikkert M, Dekker J, de Haan L.
The impact of affective symptoms on personal recovery of patients with severe mental illness.
Int J Soc Psychiatry. 2018 64(6):521-527.
Van Eck RM, Burger TJ, Vellinga A, Schirmbeck F, de Haan L. The Relationship Between Clinical and Personal Recovery in Patients With Schizophrenia Spectrum Disorders: A Systematic Review and Meta-analysis. Schizophr Bull. 2018 44(3):631-642.
Van Rooijen G, van Rooijen M, Maat A, Vermeulen JM, Meijer CJ, Ruhe HG, de Haan L, GROUP investigators , Genetic Risk and Outcome of Psychosis investigators: , Alizadeh BZ, Bartels-Velthuis AA, van Beveren NJ, Bruggeman R, Cahn W, Delespaul P, Myin-Germeys I, Kahn RS,
Schirmbeck F, Simons CJP, van Amelsvoort T, van Haren NE, van Os J, van Winkel R.
Longitudinal evidence for a relation between depressive symptoms and quality of life in schizophrenia using structural equation modeling.
Schizophr Res. 2019 208:82-89.
Vermeulen J,
Schirmbeck F, Blankers M, van Tricht M, van den Brink W, de Haan L, Genetic Risk and Outcome of Psychosis (GROUP) investigators .
Smoking, symptoms, and quality of life in patients with psychosis, siblings, and healthy controls: a prospective, longitudinal cohort study.
Lancet Psychiatry. 2019 6(1):25-34.
Vermeulen JM, Doedens P,
Schirmbeck F, van den Brink W, de Haan L.
[Implementation of a stop-smoking support program for patients and employees in a psychiatric hospital: First results].
Tijdschr Psychiatr. 2020 62(4):266-273.
Vermeulen JM,
Schirmbeck F, Blankers M, van Tricht M, Bruggeman R, van den Brink W, de Haan L, Genetic Risk and Outcome of Psychosis (GROUP) investigators .
Association Between Smoking Behavior and Cognitive Functioning in Patients With Psychosis, Siblings, and Healthy Control Subjects: Results From a Prospective 6-Year Follow-Up Study.
Am J Psychiatry. 2018 175(11):1121-1128.
Waltereit R, Eifler S,
Schirmbeck F,
Zink M.
Visual and Auditory Hallucinations Associated With Citalopram Treatment.
J Clin Psychopharmacol. 2013 33(4):583-4. Epub 2013 Jun 14.
Wijnen BFM, Pos K, Velthorst E,
Schirmbeck F, Chan HY, de Haan L, van der Gaag M, Evers SMAA, Smit F.
Economic evaluation of brief cognitive behavioural therapy for social activation in recent-onset psychosis.
PLoS ONE. 2018 13(11):e0206236.
Zink M,
Schirmbeck F, Rausch F, Eifler S, Elkin H, Solojenkina X, Englisch S, Wagner M, Maier W, Lautenschlager M, Heinz A, Gudlowski Y, Janssen B, Gaebel W, Michel TM, Schneider F, Lambert M, Naber D, Juckel G, Krueger-Oezguerdal S, Wobrock T, Hasan A, Riedel M, Müller H, Klosterkötter J, Bechdolf A.
Obsessive-compulsive symptoms in at-risk mental states for psychosis: associations with clinical impairment and cognitive function.
Acta Psychiatr Scand. 2014 130(3):214-26. Epub 2014 Feb 26.
van Dijk FA,
Schirmbeck F, Boyette LL, de Haan L, for Genetic Risk and Outcome of Psychosis (GROUP) Investigators .
Coping styles mediate the association between negative life events and subjective well-being in patients with non-affective psychotic disorders and their siblings.
Psychiatry Res. 2019 272:296-303.
van Dijk FA,
Schirmbeck F, Haan L, for Genetic Risk and Outcome of Psychosis (GROUP) Investigators .
A longitudinal analysis of the effects of neuroticism and extraversion on subjective well-being in patients with schizophrenia.
Psychiatry Res. 2018 259:538-544.
